Identification of a novel <i>MAP3K1</i> variant in a family with 46, XY DSD and partial growth hormone deficiency-Reference-Cited by-全球学者库

Identification of a novel MAP3K1 variant in a family with 46, XY DSD and partial growth hormone deficiency

Published:2022-09-13 Issue:5 Volume:26 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Cheng Yiping¹,Xu Chao¹,Yang Jiangfei²,Zhou Xinli¹,Chen Nan³

Affiliation:

1. Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China

2. Department of Radiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China

3. Department of Dermatology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. Disorders of sexual development;Allen;Obstet Gynecol Clin North Am,2009

2. 46,XY Disorders of sexual development;Domenice,2000

3. How sexually dimorphic are we? Review and synthesis;Hull;Am J Hum Biol,2003

4. Genetic analysis in inherited metabolic disorders-from diagnosis to treatment. Own experience, current state of knowledge and perspectives;Wertheim-Tysarowska;Dev Period Med,2015

5. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46,XY disorders of sex development;Berglund;J Clin Endocrinol Metab,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAP3K1 Identified as a Prognostic Biomarker in Breast Cancer After Multi-omics Bioinformatics Analysis;2023-12-20